Méryl Roudaut

Project Leader at HCS Pharma

Méryl Roudaut has been working in the industry since 2014. Méryl began their career as an Internship - master's 1 degree at Université de Bretagne Occidentale in 2014. In 2015, they were a Technician R&D and an Internship - master's 2 degree at HCS Pharma. In 2016, they were a Ph.D. Student at l'institut du thorax. Currently, they are a Project Leader at HCS Pharma since 2020.

Méryl Roudaut obtained a Bachelor degree in Biology, General from the Université de Bretagne Occidentale, between 2010 and 2013. In 2013-2014, they completed a Master's 1 degree in Molecular Toxicology at the same university. In 2014-2015, they obtained a Master's 2 degree in Pharmacology and Toxicology at the Université Paul Sabatier Toulouse III. Additionally, they obtained the UPAL (Utilisation et Protection de l'Animal de Laboratoire) level I certification from the Toulouse National Veterinary School in September 2015. Finally, they completed their Doctor of Philosophy - PhD in Biology at Nantes Université in 2020.

Location

Lille, France

Links


Org chart

No direct reports

Teams

This person is not in any teams


Offices


HCS Pharma

HCS Pharma is a biotechnology company focused on in vitro R&D, specializing in high content (HCA).


Industries

Headquarters

Loos, France

Employees

11-50

Links